Answers to angle closures quiz

Optometrists should know what is expected, what is concerning, and when to contact the surgeon.

The latest in drug and technology developments and updates from August 2026.

Host Hamza Shah, OD, MS, FAAO, is joined by Leonard Messner, OD, to discuss GLP-1s and idiopathic intracranial hypertension, inspired by Mitchell et al's paper, "The Effect of GLP-1RA Exenatide on Idiopathic Intracranial Hypertension: A Randomized Clinical Trial."

Catch up on the top stories in optometry during the week of August 24-28.

The agency assigned a PDUFA target action date of April 30, 2027.

In the latest episode of The Independent Advantage, Maria Sampalis, OD, gives a resounding "absolutely not" when posited with the question of whether or not eye care providers will be replaced by AI.

A recent study found that migraines were associated with higher adverse vision outcomes in a cohort of Norwegian adolescents.

Jem Martin, OD, discusses the accommodations and referrals any provider can offer, the red flags that should raise suspicion of CVI, and how the free TEACHCVI screening tool works in practice.